SEC Tracker
Get the app

Medifast MED

Medifast FY 2020: revenue $934.8M; diluted EPS $8.68

Form
10-K
Filed
Period
Importance
Notable
Document
10-K

Key figures from this report

These are the numbers Medifast reported for the year ended Dec 31, 2020, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

  1. Revenue$934.8MNo year-earlier figure tagged10-K income statement, on EDGAR
  2. Net income$102.9MNo year-earlier figure tagged10-K income statement, on EDGAR
  3. Diluted EPS$8.68No year-earlier figure tagged10-K income statement, on EDGAR
  4. Cash and cash equivalents$163.7MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
  5. Cash from operations$145.2MNo year-earlier figure tagged10-K cash flow statement, on EDGAR

Every year in the financial tables

View on EDGAR

Open in the app

Get an email when Medifast files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2090 and related industry codes: the same peer list as the financial tables.

  1. Farmer Brothers FARM
  2. Utz Brands UTZ public float $912M, Jun 29, 2025
  3. Coffee Holding JVA public float $17M, Apr 30, 2025, over 18 months old
  4. McCormick MKC
  5. Top Wealth Group Holding TWG

Data on this page was fetched . The filing on SEC.gov is the record.